Related Experiment Video
Updated: May 9, 2026
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
[Respiratory failure].
1Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 17, 2013
Summary
Aged patients face high mortality from acute respiratory distress syndrome (ARDS). Targeting platelet-activating factor (PAF) and cytosolic PLA2 (cPLA2) pathways may offer new treatments for this severe lung injury.
Area of Science:
- Pulmonary Medicine
- Inflammation Research
- Geriatric Medicine
Background:
- Aged individuals are highly susceptible to respiratory failure, particularly acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
- Current treatments for ARDS have limited efficacy, with mortality rates between 40-70%, highlighting the need for novel therapeutic strategies.
- The precise mechanisms underlying ARDS pathogenesis, especially in the elderly, require further elucidation.
Purpose of the Study:
- To investigate the role of platelet-activating factor (PAF) and cytosolic phospholipase A2 (cPLA2) in the development of ALI.
- To explore the potential of inhibiting PAF and cPLA2 pathways as a therapeutic approach for ALI in aged patients.
Main Methods:
- Utilized genetically-engineered mouse models to study ALI pathogenesis.
- Examined the involvement of PAF and cPLA2 signaling in the inflammatory response within the lungs.
Main Results:
- Genetically-engineered mouse studies demonstrated a significant role for PAF and cPLA2 in ALI pathogenesis.
- Evidence suggests these lipid mediators contribute to key inflammatory processes in acute lung injury.
Conclusions:
- Platelet-activating factor (PAF) and cytosolic PLA2 (cPLA2) are critical mediators in the development of acute lung injury.
- Inhibiting the PAF and cPLA2 pathways presents a promising novel therapeutic avenue for treating ALI, especially in vulnerable aged populations.
Related Concept Videos
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:30Alterations in Respiration II
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...